PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Zhang, S.* ; Schneider, L.S.* ; Vick, B. ; Grunert, M. ; Jeremias, I. ; Menche, D.* ; Müller, R.* ; Vollmar, A.M.* ; Liebl, J.*

Anti-leukemic effects of the V-ATPase inhibitor Archazolid A.

Oncotarget 6, 43508-43528 (2015)
Verlagsversion Anhang DOI
Open Access Gold
Creative Commons Lizenzvertrag
Prognosis for patients suffering from T-ALL is still very poor and new strategies for T-ALL treatment are urgently needed. Our study shows potent anti-leukemic effects of the myxobacterial V-ATPase inhibitor Archazolid A. Archazolid A reduced growth and potently induced death of leukemic cell lines and human leukemic samples. By inhibiting lysosomal acidification, Archazolid A blocked activation of the Notch pathway, however, this was not the mechanism of V-ATPase inhibition relevant for cell death induction. In fact, V-ATPase inhibition by Archazolid A decreased the anti-apoptotic protein survivin. As underlying mode of action, this work is in line with recent studies from our group demonstrating that Archazolid A induced S-phase cell cycle arrest by interfering with the iron metabolism in leukemic cells. Our study provides evidence for V-ATPase inhibition as a potential new therapeutic option for T-ALL.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
6.359
1.250
10
22
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Archazolid ; Leukemia ; Natural Compounds; Acute Lymphoblastic-leukemia; Acute Myeloid-leukemia; Vacuolar H+-atpase; Chronic Lymphocytic-leukemia; Breast-cancer Cells; Therapeutic Target; Proton Pumps; Endoplasmic-reticulum; Drug-resistance; Notch Receptor
Sprache englisch
Veröffentlichungsjahr 2015
HGF-Berichtsjahr 2016
ISSN (print) / ISBN 1949-2553
e-ISSN 1949-2553
Zeitschrift OncoTarget
Quellenangaben Band: 6, Heft: 41, Seiten: 43508-43528 Artikelnummer: , Supplement: ,
Verlag Impact Journals LLC
Begutachtungsstatus Peer reviewed
Institut(e) Research Unit Gene Vector (AGV)
POF Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-501590-001
DOI 10.18632/oncotarget.6180
WOS ID WOS:000369908400027
Scopus ID 84952891536
Erfassungsdatum 2016-12-31
[➜Korrektur melden]